Cart
sales@molnova.com
Falcarindiol
CAS No. 225110-25-8
Falcarindiol( (3R,8S)-Falcarindiol | 3(R),8(S),9(Z)-Falcarindiol )
Catalog No. M18262 CAS No. 225110-25-8
Falcarindiol is a potential new anticancer agent that exerts its activity through inducing ER stress and apoptosis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 140 | In Stock |
|
| 10MG | 222 | In Stock |
|
| 25MG | 376 | In Stock |
|
| 50MG | 536 | In Stock |
|
| 100MG | 777 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameFalcarindiol
-
NoteResearch use only, not for human use.
-
Brief DescriptionFalcarindiol is a potential new anticancer agent that exerts its activity through inducing ER stress and apoptosis.
-
DescriptionFalcarindiol is a potential new anticancer agent that exerts its activity through inducing ER stress and apoptosis. Falcarindiol induces immunosuppressive effects in vitro and in vivo and might be a novel therapy for autoimmune or allergic diseases. Falcarindiol has protective effect against CCl(4) toxicity , in part, be explained by anti-lipid peroxidation activity associated with the induction of the GSTs including GSTA4.
-
In Vitro——
-
In Vivo——
-
Synonyms(3R,8S)-Falcarindiol | 3(R),8(S),9(Z)-Falcarindiol
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research AreaOthers-Field
-
Indication——
Chemical Information
-
CAS Number225110-25-8
-
Formula Weight260.37
-
Molecular FormulaC17H24O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 150 mg/mL (576.10 mM)
-
SMILESCCCCCCCC=CC(C#CC#CC(C=C)O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
CMPF
CMPF is a microtubule protein inhibitor that can be used to study tumors.
-
Oxybenzone
Oxybenzone is an organic compound used in sunscreens. It is a derivative of benzophenone.
-
α-Terpineol
α-Terpineol has antitumour anti-inflammatory and antimicrobial activities it inhibits the growth of tumour cells through a mechanism that involves inhibition of the NF-kappaB pathway.
